About Contact Us Careers

Fibrin Sealants Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 4466
Published Date: Nov 08, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Fibrin Sealants Landscape

CSL Limited
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Baxter International, Inc.
Pfizer Inc.
Asahi Kasei Corporation
Vivostat A/S
Octapharma AG

Browse Key Market Insights with Data Illustration:

Fibrin Sealants Market Size & Share | Growth Trends 2037

In the News

Asahi Kasei Corporation has acquired Bionova Scientific, LLC, a provider of contract process development and GMP-compliant contract manufacturing services to the biopharmaceutical industry.
Grifols S.A. launched VISTASEAL plasma-protein-based bleeding-control solutions. Using Ethicon's airless spray device technology, this medication combines fibrinogen and thrombin, two plasma proteins.

Author Credits: Radhika Pawar

Report ID: 4466
Published Date: Nov 08, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of fibrin sealants is assessed at USD 1.06 billion.

The fibrin sealants market size was valued at USD 1.01 billion in 2024 and is expected to reach USD 2.13 billion by 2037, registering around 5.9% CAGR during the forecast period i.e., between 2025-2037. Worldwide growing count of surgical procedures, upsurge in hemophilia cases, spiking numbers of orthopedic surgeries, and worldwide increase in geriatric population will boost the market growth.

North America industry is likely to dominate majority revenue share of 45% by 2037, backed by significantly increasing healthcare expenditure, growing occurrence of cardiovascular diseases, and growing count of surgical procedures in the region.

The major players in the market include CSL Limited, Baxter International, Inc., Pfizer Inc., Asahi Kasei Corporation, Vivostat A/S, Octapharma AG

Inquiry Before Buying Request Free Sample